{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2023"],"condition":["Colorectal Cancer"],"disease":["Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/85063"],"location":["China"],"study_start_month":["2"],"repository":["ECRIN MDR"],"study_status":["Not yet recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Effects of general anesthesia with remimazolam on immune function and quality of postoperative recovery in patients undergoing radical colorectal cancer surgery","description":"Interventions: Group R:Remimazolam for induction and maintenance of anesthesia;Group P:Propofol for induction and maintenance of anesthesia\nPrimary outcome(s): Immune function\nStudy Design: Parallel","dates":{"creation":"2023-02-15"},"accession":"85063","cross_references":{"Chinese Clinical Trial Register":["ChiCTR2300068931"]}}